Phase 3 lidERA evaluates daily oral SERD giredestrant in ER+/HER2- early disease, including subgroup analyses by age and menopausal status after a reported 30% risk reduction. Primary ASCENT-04 data ...

Veterans reported $419 million in fraud losses in 2024 as scammers exploit military records and VA data. Here are the biggest ...

Eli Lilly just got more good news, posting promising results for its oral GLP-1 as the firm looks to unlock new sources of ...

Hydreight Technologies Inc. ("Hydreight" or the "Company") (TSXV: NURS) (OTCQB: HYDTF) (FSE: SO6), a rapidly growing digital health platform and provider of compliant healthcare infrastructure across ...

Detailed price information for Milestone Pharmaceuticals Inc (MIST-Q) from The Globe and Mail including charting and trades.

Kevin Warsh confirmed as Fed chair 54-45 as Bitcoin stalls at $77K resistance. Inflation expectations hit 4.8% while crypto ...

Kentucky has gone one-and-done at the SEC Tournament again. The Bat Cats had yet another short stay in Hoover that included a game that Nick Mingione‘s team had put in cruise control only for an ...

Carol Sturka declares her agency  I had turned to ChatGPT to help organize research notes for an upcoming keynote. I was ...

Supply chain attacks with a Dune sci-fi saga branding continue to spread across the open-source ecosystem, with a Microsoft ...

With the recent launches of Novo Nordisk’s Wegovy pill and Eli Lilly’s Foundayo, the obesity market has started to shift toward oral GLP-1 drugs. While Novo leverages its first-mover advantage with ...

The NBA Eastern Conference Finals continue tonight in Cleveland, as the Cavaliers host the New York Knicks for a pivotal Game ...